首页 | 本学科首页   官方微博 | 高级检索  
     


Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy
Authors:Blake M. Warner  Alan N. Baer  Evan J. Lipson  Clint Allen  Christian Hinrichs  Arun Rajan  Eileen Pelayo  Margaret Beach  James L. Gulley  Ravi A. Madan  Josephine Feliciano  Margaret Grisius  Lauren Long  Astin Powers  David E. Kleiner  Laura Cappelli  Ilias Alevizos
Affiliation:1. Sjögren's Syndrome and Salivary Gland Dysfunction Unit, National Institutes of Health, Baltimore, Maryland, USA;2. Sjögren's Syndrome and Salivary Gland Dysfunction Unit, National Institutes of Health, Baltimore, Maryland, USA

Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Contributed equally.;3. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;4. Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Baltimore, Maryland, USA;5. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Baltimore, Maryland, USA;6. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Baltimore, Maryland, USA;7. Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Abstract:
Keywords:Sicca syndrome  Immune checkpoint inhibitor  Immune-related adverse event  Sialadenitis  Sjögren's syndrome  Programmed cell death 1/programmed cell death ligand 1 pathway  Xerostomia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号